By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Transposagen Biopharmaceuticals, Inc. 

3624 Market Street
Suite 5E
Philadelphia  Pennsylvania  19104  U.S.A.
Phone: 215-966-6117 Fax: n/a


SEARCH JOBS








Company News
Transposagen Biopharmaceuticals, Inc.'s Footprint-Free™ Gene Editing System Corrects Beta-Thalassemia Disease Mutation In Human IPS Cells 8/8/2014 11:12:40 AM
Transposagen Biopharmaceuticals, Inc. Issued Key U.S. Patent Covering Rat Models Of Cancer 5/23/2014 9:08:25 AM
Transposagen Biopharmaceuticals, Inc. Issued Two Key U.S. Patents 11/4/2013 8:56:29 AM
Transposagen Biopharmaceuticals, Inc. Receives Over $4.3 Million in Grants and Investment 6/21/2013 9:42:18 AM
Transposagen Biopharmaceuticals, Inc. Announces the Availability of XTN™ TALENs Targeting Every Gene in the Human Genome 7/18/2012 11:04:12 AM
Transposagen Biopharmaceuticals, Inc.'s piggyBac(TM) Vectors to be Distributed by System Biosciences (SBI) 5/12/2011 7:48:42 AM
Transposagen Biopharmaceuticals, Inc. and Cellular Dynamics International Cross-License Technologies for Induced Pluripotent Stem Cells 1/5/2011 8:11:08 AM
Taconic Farms, Inc. to Distribute Transposagen Biopharmaceuticals, Inc.'s FatRat(TM) Obesity Model 12/9/2010 10:34:14 AM
Transposagen Biopharmaceuticals, Inc. Announces Exclusive License with Charles River Laboratories (Massachusetts) for p53 and Bcrp TGEM(TM) Knockout Rat Models 10/14/2010 6:55:21 AM
Transposagen Biopharmaceuticals, Inc. Announces New Product Offering: TGEM(TM) Genetically Modified Rat Models 4/22/2010 11:12:15 AM
12
//-->